Point72 Asset Management
IGMS

Point72 Asset Management’s IGM Biosciences IGMS Stock Holding History

Point72 Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,246
Closed -$187K – 2158
2024
Q2 		$187K Buy
+27,246
New +$233K ﹤0.01% 1623
2023
Q2 		– Sell
-129,740
Closed -$1.78M – 2450
2023
Q1 		$1.78M Buy
+129,740
New +$2.68M 0.01% 1000

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's IGMS Position: Q3 2024 in Review

Point72 Asset Management sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 27,246 shares — an estimated $187K sold.

Point72 Asset Management first reported a position in IGMS in Q1 2023 and held it in 2 quarters. The position peaked at $1.78M in Q1 2023. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Point72 Asset Management reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Point72 Asset Management sold 27,246 IGM Biosciences shares in Q3 2024, an estimated $187K.
  • Point72 Asset Management first reported a position in IGM Biosciences in Q1 2023 and held it in 2 quarters.
  • Point72 Asset Management's IGM Biosciences position peaked at $1.78M in Q1 2023.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.